The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- PMID: 21514249
- PMCID: PMC3312027
- DOI: 10.1016/j.jalz.2011.03.008
The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Abstract
The National Institute on Aging and the Alzheimer's Association charged a workgroup with the task of developing criteria for the symptomatic predementia phase of Alzheimer's disease (AD), referred to in this article as mild cognitive impairment due to AD. The workgroup developed the following two sets of criteria: (1) core clinical criteria that could be used by healthcare providers without access to advanced imaging techniques or cerebrospinal fluid analysis, and (2) research criteria that could be used in clinical research settings, including clinical trials. The second set of criteria incorporate the use of biomarkers based on imaging and cerebrospinal fluid measures. The final set of criteria for mild cognitive impairment due to AD has four levels of certainty, depending on the presence and nature of the biomarker findings. Considerable work is needed to validate the criteria that use biomarkers and to standardize biomarker analysis for use in community settings.
Copyright © 2011 The Alzheimer's Association. All rights reserved.
Conflict of interest statement
With regard to potential conflicts of interest, Marilyn Albert serves as a consultant to Genentech and Eli Lilly and receives grants to her institution from GE Healthcare. Steven DeKosky serves as a consultant to Eisai, Merck, Elan/Wyeth, Novartis, he serves on the advisory board of Pfizer and provides clinical services to United Healthcare. Dennis Dickson report no conflicts. Bruno Dubois serves as a consultant to Affiris, Pierre Fabre, and Eisai, serving on a scientific advisory board for Bristol-Meyers Squibb, Roche, Pfizer, Eli Lilly, and GE Healthcare, and receives grants to his institution from Novartis, Roche, and Eisai. Howard Feldman is an employee of Bristol Meyers Squibb (BMS) and holds stock in BMS; he serves as a consultant to Servier, Glia Scientific, and Pfizer, and serves on a scientific advisory board for Elan, Janssen, Canada, and Wyeth. Nick Fox serves as a consultant (payment to Institute of Neurology) for BMS, Elan/Janssen, Eli Lilly, GE, Lundbeck, and Pfizer/Wyeth. The Institute of Neurology (Nick Fox) has conducted image analysis for Elan/Janssen, Lundbeck, and Pfizer/Wyeth. Anthony Gamst reports no conflicts. David Holtzman serves as a consultant for Bristol-Myers Squibb, Pfizer, and Innogenetics; he serves on a scientific advisory board for En Vivo, Satori, and C2N Diagnostics; and receives grants to his institution from Pfizer, Eli Lilly, and Astra Zeneca. William Jagust serves as a consultant to Genentech, Bayer Healthcare, GE Healthcare. Synarc, Otsuka Pharmaceuticals, Janssen Alzheimer Immunotherapy, Merck, and Tau Rx. Ronald Petersen serves as a consultant for Elan Pharmaceuticals and GE Healthcare and serves on data monitoring committees for Pfizer, Inc., Janssen Alzheimer Immunotherapy. Peter Snyder serves as a consultant to CogState Ltd. Maria Carrillo is an employee of the Alzheimer’s Association and reports no conflicts. Bill Thies is an employee of the Alzheimer’s Association and reports no conflicts. Creighton Phelps is an employee of the U.S. Government and reports no conflicts.
Comment in
-
Commentary on "Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease." Addressing the challenge of Alzheimer's disease in the 21st century.Alzheimers Dement. 2011 May;7(3):335-7. doi: 10.1016/j.jalz.2011.04.002. Alzheimers Dement. 2011. PMID: 21575876 No abstract available.
Similar articles
-
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.Alzheimers Dement. 2011 May;7(3):263-9. doi: 10.1016/j.jalz.2011.03.005. Epub 2011 Apr 21. Alzheimers Dement. 2011. PMID: 21514250 Free PMC article.
-
Commentary on "Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease." Addressing the challenge of Alzheimer's disease in the 21st century.Alzheimers Dement. 2011 May;7(3):335-7. doi: 10.1016/j.jalz.2011.04.002. Alzheimers Dement. 2011. PMID: 21575876 No abstract available.
-
Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.Alzheimers Dement. 2011 May;7(3):257-62. doi: 10.1016/j.jalz.2011.03.004. Epub 2011 Apr 21. Alzheimers Dement. 2011. PMID: 21514247 Free PMC article.
-
[The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].Rev Neurol (Paris). 2012 Jun;168(6-7):471-82. doi: 10.1016/j.neurol.2011.11.007. Epub 2012 May 12. Rev Neurol (Paris). 2012. PMID: 22579080 Review. French.
-
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.Alzheimers Dement. 2011 May;7(3):280-92. doi: 10.1016/j.jalz.2011.03.003. Epub 2011 Apr 21. Alzheimers Dement. 2011. PMID: 21514248 Free PMC article.
Cited by
-
Data-driven retrieval of population-level EEG features and their role in neurodegenerative diseases.Brain Commun. 2024 Jul 31;6(4):fcae227. doi: 10.1093/braincomms/fcae227. eCollection 2024. Brain Commun. 2024. PMID: 39086629 Free PMC article.
-
Diagnostic performance of light reflex pupillometry in Alzheimer's disease.Alzheimers Dement (Amst). 2024 Jul 31;16(3):e12628. doi: 10.1002/dad2.12628. eCollection 2024 Jul-Sep. Alzheimers Dement (Amst). 2024. PMID: 39086497 Free PMC article.
-
Testing central auditory processing abilities in older adults with and without dementia using the consonant-vowel dichotic listening task.Front Dement. 2023 Nov 17;2:1207546. doi: 10.3389/frdem.2023.1207546. eCollection 2023. Front Dement. 2023. PMID: 39081992 Free PMC article.
-
Dimensions of cognitive reserve and their predictive power of cognitive performance and decline in the elderly.Front Dement. 2023 Aug 31;2:1099059. doi: 10.3389/frdem.2023.1099059. eCollection 2023. Front Dement. 2023. PMID: 39081990 Free PMC article.
-
Cerebrovascular lesion loads and accelerated brain aging: insights into the cognitive spectrum.Front Dement. 2024 Jun 21;3:1380015. doi: 10.3389/frdem.2024.1380015. eCollection 2024. Front Dement. 2024. PMID: 39081605 Free PMC article.
References
-
- McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Jr, Kawas CH, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging–Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:263–9. - PMC - PubMed
-
- Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al. Towards defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging–Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:280–92. - PMC - PubMed
-
- Lyketsos C, Colenda C, Beck C, Blank K, Doraiswamy M, Kalunian D, et al. Position statement of the American Association for Geriatric Psychiatry regarding principles of care for patients with dementia resulting from Alzheimer’s disease. Am J Geriatr Psychiatry. 2006;14:561–72. - PubMed
-
- Petersen RC, Smith G, Waring S, Ivnik R, Tangalos E, Kokmen E, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56:303–8. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical